Refine Search
(0)
(6)
(17)
(27)

Hyperlipidemia - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H2 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperlipidemia, ...

Lipodystrophy - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Lipodystrophy - Pipeline Review, H2 2016’, provides an overview of the Lipodystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lipodystrophy, com...

Ageing - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ageing - Pipeline Review, H2 2016’, provides an overview of the Ageing pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ageing, complete with analysis b...

Hypertriglyceridemia - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypertriglyceridemia - Pipeline Review, H2 2016’, provides an overview of the Hypertriglyceridemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Diabetic Retinopathy - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Retinopathy - Pipeline Review, H1 2018’, provides an overview of the Diabetic Retinopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Cushing's Syndrome - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cushing's Syndrome - Pipeline Review, H1 2018’, provides an overview of the Cushing's Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Hypercholesterolemia - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2018’, provides an overview of the Hypercholesterolemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hype...

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2018’, provides an overview of the Pituitary ACTH Hypersecretion (Cushing Disease) pipeline landscape.

The report provides comprehensive info...

Hyperinsulinemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperinsulinemia - Pipeline Review, H1 2018’, provides an overview of the Hyperinsulinemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperinsulin...

Hyperglycemia - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H1 2018’, provides an overview of the Hyperglycemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperglycemia, com...

Familial Amyloid Neuropathies - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Familial Amyloid Neuropathies - Pipeline Review, H1 2018’, provides an overview of the Familial Amyloid Neuropathies pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Hyperuricemia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H2 2018’, provides an overview of the Hyperuricemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperuricemia, com...

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018’, provides an overview of the Proliferative Diabetic Retinopathy (PDR) pipeline landscape.

The report provides comprehensive information on the...

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Pompe Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pompe Disease - Pipeline Review, H2 2018’, provides an overview of the Pompe Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pompe Disease, com...